Explore more
News
Pfizer, Ursula von der Leyen and Eu
Digest more
Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...
A case against one of the major COVID-19 vaccine providers filed by the Kansas Attorney General will be heard at the state ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...
But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...
The EU’s general court has dismissed the European Commission’s refusal to disclose text messages its president Ursula von der ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
MedPage Today on MSN2d
Pfizer Confirms: Leading JAK Inhibitor Often Comes With Weight GainPatients taking tofacitinib (Xeljanz) in the drug's late-stage and post-marketing studies were more likely than those on ...
Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
13hon MSN
We recently published a list of 13 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback